Atlas Trials

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Clinical trial NCT03035331 · COMPLETED

Trial details

NCT number
NCT03035331
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone LymphomaRecurrent Non-Hodgkin LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell LymphomaRecurrent T-Cell Non-Hodgkin LymphomaSmall Lymphocytic Lymphoma
Start date
2017-08-15
Primary completion
2022-01-25
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.